References
- Ablin A, Isaacs H I. Germ cell tumors. Principles and Practice of Pediatric Oncology, PA Pizzo, DG Poplack. J.B. Lippincott Co., Philadelphia 1989; 867–887
- Mackay E N, Sellers A H. A statistical review of malignant testicular tumors based on the experience of the Ontario Foundation Clinics, 1938–1961. Can Med Assoc J. 1966; 94: 889–899
- Williams S D, Birch R, Einhorn L H. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etopside. N Engl J Med. 1987; 316: 1435–1440
- Nicols C R, Andersen J, Lazarus H M. High-dose carboplatin and etopside with autologous bone marrow transplantation in refractory germ cell cancer: An Eastern Cooperative Oncology Group Protocol. J Clin Oncol. 1992; 10: 558–563
- Motzer R J, Gulati S C, Crown J P. High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better tolerated. Cancer 1992; 69: 550–556
- Logothetis C J, Samuels M L, Trindade A. The management of brain metastases in germ cell tumors. Cancer 1982; 49: 12–18
- Levin V, Freeman D, Landahl H. Permeability characteristics of brain adjacent to tumor in rats. Arch Neurol. 1975; 32: 785–791
- Harada K, Kiya K, Kobayashi M, Takeda T. Pharmacokinetics of a new water-soluble nitrosourea (MCNU) on brain tumors. Cancer Chemother. 1981; 8: 735–742
- Murphy B R, Breeden E S, Donohue J P. Surgical salvage of chemorefractory germ cell tumors. J Clin Oncol. 1993; 11: 324–329
- Takaue Y, Watanabe T, Hoshi Y. Effectiveness of high-dose MCNU therapy and hematopoietic stem cell autografts treatment of childhood acute leukemia/lymphoma with high-risk features. Cancer 1991; 67: 1830–1837